Evidence map›Paper›PMID 25348715›Full record

ArticleMolecular and cellular biology2015

Kinase regulation by hydrophobic spine assembly in cancer.

Jiancheng Hu, Lalima G Ahuja, Hiruy S Meharena, Natarajan Kannan, Alexandr P Kornev, Susan S Taylor, Andrey S Shaw

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 138 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. BRAFScience advances · 2023
    Article
  20. Article

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Jiancheng HuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri, USA.ORCID http://orcid.org/0000-0003-1615-0030
Lalima G AhujaDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA.
Hiruy S MeharenaDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA.
Natarajan KannanDepartment of Biochemistry and Molecular Biology, University of Georgia, Athens, Georgia, USA.
Alexandr P KornevDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California, USA.
Susan S TaylorDepartment of Pharmacology, University of California, San Diego, La Jolla, California, USA Department of Chemistry and Biochemistry, University of California, San Diego, La Jolla, California, USA Howard Hughes Medical Institute, University of California, San Diego, La Jolla, California, USA staylor@ucsd.edu shaw@pathbox.wustl.edu.
Andrey S ShawDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, Missouri, USA Howard Hughes Medical Institute, Washington University School of Medicine, St. Louis, Missouri, USA staylor@ucsd.edu shaw@pathbox.wustl.edu.
Howard Hughes Medical Institute · USUniversity of California San Diego · USUniversity of Georgia · US

Funding

Protein Kinase: Primary Structure and cAMP InteractionsR01GM019301 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TAYLOR, SUSAN S. · 1985 to 2013
$3.4M
Structure and Function of the Immunological SynapseR37AI057966 · NIAID · WASHINGTON UNIVERSITY · PI SHAW, ANDREY S. · 2004 to 2013
$3.2M
PROTEIN KINASE: PRIMARY STRUCTURE AND CAMP INTERACTIONR37GM019301 · NIGMS · UNIVERSITY OF CALIFORNIA SAN DIEGO · PI TAYLOR, SUSAN S · 1995 to 2004
$2.0M
NIAID NIH HHS AI57966NIAID NIH HHS R37 AI057966NIDDK NIH HHS DK96688NIGMS NIH HHS GM19301NIGMS NIH HHS R01 GM019301NIGMS NIH HHS R37 GM019301
6 · The paper itself

Abstract

A new model of kinase regulation based on the assembly of hydrophobic spines has been proposed. Changes in their positions can explain the mechanism of kinase activation. Here, we examined mutations in human cancer for clues about the regulation of the hydrophobic spines by focusing initially on mutations to Phe. We identified a selected number of Phe mutations in a small group of kinases that included BRAF, ABL1, and the epidermal growth factor receptor. Testing some of these mutations in BRAF, we found that one of the mutations impaired ATP binding and catalytic activity but promoted noncatalytic allosteric functions. Other Phe mutations functioned to promote constitutive catalytic activity. One of these mutations revealed a previously underappreciated hydrophobic surface that functions to position the dynamic regulatory αC-helix. This supports the key role of the C-helix as a signal integration motif for coordinating multiple elements of the kinase to create an active conformation. The importance of the hydrophobic space around the αC-helix was further tested by studying a V600F mutant, which was constitutively active in the absence of the negative charge that is associated with the common V600E mutation. Many hydrophobic mutations strategically localized along the C-helix can thus drive kinase activation.

Indexed as

Gene Expression Regulation, NeoplasticAdenosine TriphosphateAllosteric SiteCatalysisErbB ReceptorsHEK293 CellsHistidineHumansHydrophobic and Hydrophilic InteractionsMethionineModels, MolecularMutationNeoplasmsPhosphotransferasesProtein Structure, SecondaryProto-Oncogene Proteins B-rafAdenosine TriphosphateBRAF protein, humanErbB ReceptorsHistidineMethioninePhosphotransferasesProto-Oncogene Proteins B-rafProto-Oncogene Proteins c-abl

Identifiers

PMID25348715
PMCPMC4295384
OpenAlexW2126329788

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.